EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Polycystic Ovary Syndrome Attenuates TSH-Lowering Effect of Metformin in Young Women with Subclinical Hypothyroidism

Robert Krysiak iD, Karolina Kowalcze iD, Johannes Ott iD, Sofia Burgio iD, Simona Zaami iD, Bogusław Okopień iD

Pharmaceuticals · 01.08.2025 · 18 (8) · 1149

DOI: 10.3390/ph18081149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 01.08.2025. Verfasst von Robert Krysiak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia in Katowice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The effect of metformin on the secretory function of thyrotropic cells is sex-dependent. The current study aimed to investigate whether the impact of this drug on activity of the hypothalamic–pituitary–thyroid axis in women is impacted by the androgen status of patients.

Methods

The study population included 48 levothyroxine-naïve reproductive-aged women with subclinical hypothyroidism and prediabetes receiving 3.0 g of metformin daily. Women with (n = 24) and without (n = 24) polycystic ovary syndrome were matched for age, insulin sensitivity, TSH, and reasons for thyroid hypofunction. Circulating levels of glucose, glycated hemoglobin, insulin, TSH, thyroid hormones, gonadotropins, androgens, estradiol, SHBG, prolactin, ACTH, and IGF-1 were measured before metformin treatment and six months later.

Results

At entry, women with and without polycystic ovary syndrome differed in LH, LH/FSH ratio, androgens, and estradiol. The decrease in TSH, fasting glucose and glycated hemoglobin, and the improvement in insulin sensitivity were less pronounced in women with than in women without polycystic ovary syndrome. In each group, there were no differences in the impact on TSH and thyroid hormones between patients with subclinical hypothyroidism of autoimmune and non-autoimmune origin. The changes in TSH inversely correlated with total testosterone and free androgen index. Only in women with coexisting polycystic ovary syndrome, did metformin slightly reduce LH, LH/FSH ratio, testosterone, and free androgen index.

Conclusions

The results suggest that concurrent polycystic ovary syndrome attenuates metformin action on TSH secretion, which can be explained by increased androgen production. Moreover, the drug seems to alleviate PCOS-associated changes in the activity of the reproductive axis.

Schlagwörter

Stichwörter der Autor:innen

adenohypophysishyperandrogenismhypothyroidisminsulin sensitivitymetforminreproductive-aged women

Autor:innen und Institutionen

  • Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Medyków 18, 40-752 Katowice, Poland.
  • Department of Pediatrics in Bytom, Faculty of Health Sciences in Katowice, Medical University of Silesia, Stefana Batorego 15, 41-902 Bytom, Poland.
  • Department of Pathophysiology, Faculty of Medicine, Academy of Silesia, Rolna 43, 40-555 Katowice, Poland.
  • Clinical Division of Gynecologic Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, 1090 Vienna, Austria.
  • Maternal and Child Department with Pediatric Emergency Area, Villa Sofia-V. Cervello Hospital, University of Palermo, 90128 Palermo, Italy.
  • Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, 00161 Rome, Italy.

ORCID-Profile: Robert Krysiak, Karolina Kowalcze, Johannes Ott, Sofia Burgio, Simona Zaami, Bogusław Okopień

Förderung

  • Medical University of Silesia in Katowice

Zitieren

APA

Krysiak, R., Kowalcze, K., Ott, J., Burgio, S., Zaami, S., & Okopień, B. (2025). Polycystic Ovary Syndrome Attenuates TSH-Lowering Effect of Metformin in Young Women with Subclinical Hypothyroidism. Pharmaceuticals, 18(8), 1149. https://doi.org/10.3390/ph18081149

Vancouver

Krysiak R, Kowalcze K, Ott J, Burgio S, Zaami S, Okopień B. Polycystic Ovary Syndrome Attenuates TSH-Lowering Effect of Metformin in Young Women with Subclinical Hypothyroidism. Pharmaceuticals. 2025;18(8):1149. doi:10.3390/ph18081149

BibTeX
@article{Krysiak2025,
  author = {Krysiak, Robert and Kowalcze, Karolina and Ott, Johannes and Burgio, Sofia and Zaami, Simona and Okopień, Bogusław},
  title = {Polycystic Ovary Syndrome Attenuates TSH-Lowering Effect of Metformin in Young Women with Subclinical Hypothyroidism},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {8},
  pages = {1149},
  doi = {10.3390/ph18081149}
}
Kostenlos starten →